Market Place
Sourcing Support
FDA approves record eight biosimilars in H1 2024; okays first interchangeable biosimilars for Eylea
Biologics, or complex drugs that are derived from living organisms, have revolutionized treatment of
Top Pharma Companies & Drugs in 2023: Merck’s Keytruda emerges as top-selling drug; Novo, Lilly sales skyrocket
The pharma industry clearly recalibrated itself in 2023, turning its focus away from Covid and onto
FDA reports 62.5% growth in new drug approvals in H1 2023; Health Canada sees drop
After a year when
drug approvals by the US Food and Drug Administration
(FDA) slipped to the lowes
